Alliance Pharma PLC Major Interest in Shares (5907E)
April 11 2014 - 2:00AM
UK Regulatory
TIDMAPH
RNS Number : 5907E
Alliance Pharma PLC
11 April 2014
For immediate release 11 April 2014
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Major Interest in Shares
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical
company, was informed on 10 April 2014 that on 9 April 2014, Nigel
Wray purchased 1,550,000 ordinary shares of 1p each in the
Company.
Mr Wray's resultant holding is 39,656,995 ordinary shares,
equivalent to 15.02% of the Company's issued share capital.
Mr Wray's Ordinary Shares are held as follows:
Nominee Number of ordinary shares
Pershing Nominees Limited 14,992,407
Roy Nominees Limited 24,664,588
--------------------------
For further information:
Alliance Pharma plc + 44 (0) 1249 466966
John Dawson, Chief Executive
Richard Wright, Finance Director
Buchanan + 44 (0) 20 7466 5000
Mark Court / Fiona Henson / Sophie Cowles
Numis Securities Limited + 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Oliver
Cardigan
Corporate Broking: David Poutney
Notes to editors:
Alliance, founded in 1998, is an AIM listed speciality
pharmaceutical company based in Chippenham, Wiltshire, UK. The
Company has a strong track record of acquiring the rights to
established niche products and owns or licenses the rights to more
than 60 pharmaceutical products and continues to explore
opportunities to expand the range.
Alliance joined the AIM market of the London Stock Exchange in
December 2003 and trades under the symbol APH.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLSFSFMSFLSELL
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2023 to Apr 2024